The law that was passed Nov. 12 to fund the federal government amends that regulation by setting a cap on the concentration ...

Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy (ART), according to new research from Texas Biomedical Research Institute.

Depending on who you ask, THCA is either the future of cannabis or the latest hemp loophole. It’s the molecule turning “legal” hemp flower into a legitimate high—the chemistry trick that’s reshaping ...

A sedan drifts past. The driver’s window rolls down, unleashing a billowing plume of white smoke into the chill air as they light up, driving with one hand on the wheel. It’s not tobacco, said Bob ...

Keith Villa, who invented Blue Moon Belgian White, thinks cannabis-infused beer might take off; he and his wife, Jodi, both CU Boulder alums, have launched an alcohol-free brewery that could help lead ...

A new study published in the journal Biosensors and Bioelectronics introduces an electrochemical sensor designed to detect cannabinoids with high precision. For the study, a research team from ...

Introduction: Among diverse chemical profile of Cannabis sativa L., over 100 phytocannabinoids have been identified. The major cannabinoids Δ-9-THC and CBD are well-studied, with approved palliative ...

Gov. Greg Abbott on Sunday vetoed Texas’ proposed ban on THC, splitting with lawmakers in a shock move that saves the state’s booming hemp industry and kills, for now, one of Lt. Gov. Dan Patrick’s ...

Pro-THC advocates' and business owners' relentless efforts proved at least temporarily successful late Sunday after Texas Gov. Greg Abbott opted to veto a looming ban on consumable hemp products.

Texas is on the cusp of banning all recreational THC products after lawmakers passed a bill to reverse the unintended effects of hemp laws that led to a boom in shops selling gummies, joints, vapes ...

Molecular profiling of neoadjuvant immunochemotherapy and identification of residual cancer cells in pCR NSCLC: A single-cell analysis of CTONG 1804 clinical trial.